Long-term use of a product containing N-nitroso-quinapril may be associated with an increased cancer risk based on data from closely related nitrosamine compounds. Aurobindo Pharma USA has voluntarily ...
RECALLED Irbesartan-and hydrochlorothiazide lots. Lupin N-nitroso-irbesartan is a probable human carcinogen based on results from laboratory tests. Lupin Pharmaceuticals is voluntarily recalling all ...
RALEIGH, N.C., April 1, 2026 /PRNewswire/ -- Accord Healthcare, Inc., a leading generic pharmaceutical company, committed to improving access to affordable medicines, today announced the re‑launch of ...
WASHINGTON (WJLA) — Pfizer announced a nationwide voluntary recall of blood pressure medicationbecause of high levels of nitrosamine, which can increase the risk of cancer. According to the U.S. Food ...
Pfizer is voluntarily recalling Accuretic (quinapril HCl/hydrochlorothiazide) tablets distributed by Pfizer as well as two authorized generics distributed by Greenstone (quinapril and ...
Eleven lots of blood pressure medication quinapril and quinapril HCI/hydrochlorothiazide made by Pfizer and sold under a brand name and distributed as authorized generics have been recalled. Six lots ...
Lupin Pharmaceuticals is recalling all batches of irbesartan tablets USP 75 mg, 150 mg, and 300 mg and irbesartan and hydrochlorothiazide (HCTZ) tablets USP 150 mg/12.5 mg and 300 mg/12.5 mg because ...
Glenmark Pharmaceuticals Inc. in Elmwood Park, N.J., is recalling the pills, which are in 2.5 mg and 6.25 mg doses.
Over 11,000 bottles of a high blood pressure medication have been recalled for potential cross contamination with another drug. Glenmark Pharmaceuticals Inc., based in New Jersey, has voluntarily ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results